Dr Wealth
  • Articles
    • Singapore Stocks
    • Malaysia Stocks
    • China Stocks
    • US Stocks
    • REIT
    • ETF
    • Fixed Income
    • Personal Finance
    • CPF
    • Property
    • Cryptocurrency
  • Videos
    • Dr Wealth YouTube
    • Dr Wealth TikTok
    • Early Retirement Investor
  • Newsletters
    • Dr Wealth Weekly Newsletter (Free)
    • Growth Dragons
    • Finbite Insights
  • Courses
    • Intelligent Investors Immersive
    • Turbo Stocks Trading
    • Early Retirement Masterclass
    • All-Weather Portfolio Masterclass
    • Cryptocurrency Masterclass
    • Property Investing Course
No Result
View All Result
Join Newsletter
Dr Wealth
  • Articles
    • Singapore Stocks
    • Malaysia Stocks
    • China Stocks
    • US Stocks
    • REIT
    • ETF
    • Fixed Income
    • Personal Finance
    • CPF
    • Property
    • Cryptocurrency
  • Videos
    • Dr Wealth YouTube
    • Dr Wealth TikTok
    • Early Retirement Investor
  • Newsletters
    • Dr Wealth Weekly Newsletter (Free)
    • Growth Dragons
    • Finbite Insights
  • Courses
    • Intelligent Investors Immersive
    • Turbo Stocks Trading
    • Early Retirement Masterclass
    • All-Weather Portfolio Masterclass
    • Cryptocurrency Masterclass
    • Property Investing Course
No Result
View All Result
Dr Wealth
No Result
View All Result

636% increase in Medtecs International Corporation Limited (SGX: 546) 3Q revenue, driven by Covid-19

Dr Wealth by Dr Wealth
October 14, 2020
in Stocks
0
636% increase in Medtecs International Corporation Limited (SGX: 546) 3Q revenue, driven by Covid-19

Medtecs International Corporation Limited (SGX:546) announced its unaudited results for the third quarter ended 30 September 2020 (3Q 2020) on 13 October 2020.

  • Company’s revenue increased 636% year-on-year to reach US$124.6 million
  • Net Profit after tax increased 1,115 times (or 111,466%) to reach US$45.7 million
Source: Medtecs unaudited results announcement

In the first 3 quarters of 2020,

You might also like

5 Singapore Small-Mid Caps That EQDP Managers Might Be Buying

5 Singapore Small-Mid Caps That EQDP Managers Might Be Buying

April 30, 2026
Padini Got Slapped with a Corruption Probe and Crashed 27%. Is the 5% Yield a Value Trap or a Golden Buy?

Padini Got Slapped with a Corruption Probe and Crashed 27%. Is the 5% Yield a Value Trap or a Golden Buy?

April 29, 2026
  • Group total revenue increased 474% year-on-year to reach US$287.2 million
  • Net Profit after tax increased 198 times (or 19,767%) to reach US$84.6 million
Source: Medtecs unaudited results announcement

Earning per share for the first 3 quarters of 2020 was 15.404 US cents.

This phenomenal earnings is a result of the surge in global demand for personal protective equipment (PPE) due to Covid-19.

With the ongoing Covid-19 pandemic and ongoing uncertainties on the development of a safe and effect, market demand for PPE is expected to remain strong. Medtecs expects to report record revenue and profit in the fourth quarter and financial year ending 31 December 2020.

Medtecs International Corporation Limited is a well-known healthcare products and services provider and is a leading manufacturer of a wide range of medical consumables, and hospital and workwear apparels. Medtecs also provides hospitals in Taiwan and the Philippines with integrated services which include rental and laundry of linens, management of laundry facilities, hospital automation and other non-core hospital functions.

Medtecs shares rose 4.73 % on Wednesday 14 October, up 0.07 cents to S$1.55 as of 9.31AM. Medtecs shares have increased 3130% YTD, up from 0.048 cents.

Dr Wealth

Dr Wealth

Dr Wealth provides trusted financial education to individuals. We teach investment courses because we believe every retail investor has the right to success.

Related Stories

5 Singapore Small-Mid Caps That EQDP Managers Might Be Buying

5 Singapore Small-Mid Caps That EQDP Managers Might Be Buying

by Alex Yeo
April 30, 2026
0

The Equity Market Development Programme (EQDP) is a billion-dollar initiative by the Monetary Authority of Singapore (MAS) and the Financial...

Padini Got Slapped with a Corruption Probe and Crashed 27%. Is the 5% Yield a Value Trap or a Golden Buy?

Padini Got Slapped with a Corruption Probe and Crashed 27%. Is the 5% Yield a Value Trap or a Golden Buy?

by Joo Parn (JP)
April 29, 2026
0

The Malaysian equities market is notoriously sensitive to regulatory headlines, and the recent bloodbath in Padini Holdings Berhad (KLSE: PADINI)...

Why I Bought Nanofilm at 60 cents and Made More than 150% to Date

Why I Bought Nanofilm at 60 cents and Made More than 150% to Date

by Alex Yeo
April 28, 2026
0

Buying Nanofilm Technologies International (NTI) (SGX:MZH) at ~60 cents actually isn’t as crazy as it might look today—there is actually...

10 Singapore Blue Chips Are Up ~10%+ YTD. Too Late? Is Buying the Laggards Even a Good Idea?

10 Singapore Blue Chips Are Up ~10%+ YTD. Too Late? Is Buying the Laggards Even a Good Idea?

by Qi Yang
April 23, 2026
0

In 2026, the Singapore market has attracted investor interest after a strong rally in 2025, when the Straits Times Index...

BigFatPurse Pte Ltd

140 Paya Lebar Road, #06-12
AZ @ Paya Lebar
Singapore 409015
Tel: 65-9812 0411
Email: admin@drwealth.com

Subscribe for actionable market insights in your inbox!

  • Facebook
  • Instagram
  • YouTube
  • TikTok
  • X
  • Telegram

About Us

Disclaimer

Privacy Policy

© Dr Wealth 2026

No Result
View All Result
  • Articles
    • Singapore Stocks
    • Malaysia Stocks
    • China Stocks
    • US Stocks
    • REIT
    • ETF
    • Fixed Income
    • Personal Finance
    • CPF
    • Property
    • Cryptocurrency
  • Videos
    • Dr Wealth YouTube
    • Dr Wealth TikTok
    • Early Retirement Investor
  • Newsletters
    • Dr Wealth Weekly Newsletter (Free)
    • Growth Dragons
    • Finbite Insights
  • Courses
    • Intelligent Investors Immersive
    • Turbo Stocks Trading
    • Early Retirement Masterclass
    • All-Weather Portfolio Masterclass
    • Cryptocurrency Masterclass
    • Property Investing Course

© Dr Wealth 2026

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?